Although hospital consolidation has not shown the benefits proponents had touted, it is inevitable that there will be consolidation in healthcare, because the environment is too challenging for smaller hospitals and many physician practices, explained Paul Ginsburg, PhD.
Although hospital consolidation has not shown the benefits proponents had touted, it is inevitable that there will be consolidation in healthcare, because the environment is too challenging for smaller hospitals and many physician practices, explained Paul Ginsburg, PhD, Norman Topping Chair in Medicine and Public Policy and professor of the practice of health policy and management at the University of Southern California Sol Price School of Public Policy.
Transcript (slightly modified for readability)
I think it's inevitable that healthcare markets are going to become more consolidated. Part of it is the environment for a lot of physician practices and hospitals, particularly smaller hospitals, is not a very good environment.
The future is going to be reformed payment methods, a lot of need for health information technology, a lot of reporting on quality—this is a very challenging world for smaller organizations. So some consolidation is going to make sense for them, to be part of larger organizations, to be able to function in this new world.
On the other hand there are lots of things that can be done to address and limit the degree to which prices increase due to greater consolidation. I think the most powerful tool is narrow, or limited, provider networks that are in health plans. And we've seen this with the public exchanges in the Affordable Care Act, that many of the insurance plans offered are limited network plans and they have substantially lower premiums than plans with broad networks. And that's all because of the limited network plan's ability to negotiate lower prices.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More